Harrow Labs produces a drug used for the treatment of arthritis. The drug is produced in batches. i (Click the icon to view additional information.) In March, Harrow, which had no opening inventory, processed one batch of chemicals. It sold 1,500 gallons of product for human use and 400 gallons of the veterinarian product. Harrow uses the net realizable value method for allocating joint production costs. Read the requirements.
Harrow Labs produces a drug used for the treatment of arthritis. The drug is produced in batches. i (Click the icon to view additional information.) In March, Harrow, which had no opening inventory, processed one batch of chemicals. It sold 1,500 gallons of product for human use and 400 gallons of the veterinarian product. Harrow uses the net realizable value method for allocating joint production costs. Read the requirements.
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
![Harrow Labs produces a drug used for the treatment of arthritis. The drug is produced in batches.
i (Click the icon to view additional information.)
In March, Harrow, which had no opening inventory, processed one batch of chemicals. It sold 1,500 gallons of product for human use and 400 gallons of the veterinarian product. Harrow uses the net realizable value method for
allocating joint production costs.
Read the requirements.
Requirement 1. How much in joint costs does Harrow allocate to each product? (Do not round intermediary calculations. Only round the amount you input in the cell to the nearest dollar.)
Joint costs allocated to human product
Joint costs allocated to veterinarian product
Requirements
1. How much in joint costs does Harrow allocate to each product?
2. Compute the cost of ending inventory for each of Harrow's products.
3. If Harrow were to use the constant gross-margin percentage NRV
method instead, how would it allocate its joint costs?
4. Calculate the gross margin on the sale of the product for human use in March
under the constant gross-margin percentage NRV method.
C
5. Suppose that the separation process also yields 260 pints of a toxic
byproduct. Harrow currently pays a hauling company $6,100 to dispose of this
byproduct. Harrow is contacted by a firm interested in purchasing a modified
form of this byproduct for a total price of $7,300. Harrow estimates that it will
cost about $40 per pint to do the required modification. Should Harrow accept
the offer?
X
More info
Chemicals costing $45,000 are mixed and heated, then a unique separation
process then extracts the drug from the mixture. A batch yields a total of 3,600
gallons of the chemicals. The first 3,000 gallons are sold for human use while the
last 600 gallons, which contain impurities, are sold to veterinarians. The costs
of mixing, heating, and extracting the drug amount to $649,200 per batch. The
output sold for human use is pasteurized at a total cost of $168,000 and is sold for
$630 per gallon. The product sold to veterinarians is irradiated at a cost of $19 per
gallon and is sold for $490 per gallon.
Print
Done
X](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2Fc47f04bf-22a9-4274-aa74-6185f2bc371a%2F370cbeb1-1ec5-4491-8a95-ad4f570840cc%2F3dms8i4_processed.png&w=3840&q=75)
Transcribed Image Text:Harrow Labs produces a drug used for the treatment of arthritis. The drug is produced in batches.
i (Click the icon to view additional information.)
In March, Harrow, which had no opening inventory, processed one batch of chemicals. It sold 1,500 gallons of product for human use and 400 gallons of the veterinarian product. Harrow uses the net realizable value method for
allocating joint production costs.
Read the requirements.
Requirement 1. How much in joint costs does Harrow allocate to each product? (Do not round intermediary calculations. Only round the amount you input in the cell to the nearest dollar.)
Joint costs allocated to human product
Joint costs allocated to veterinarian product
Requirements
1. How much in joint costs does Harrow allocate to each product?
2. Compute the cost of ending inventory for each of Harrow's products.
3. If Harrow were to use the constant gross-margin percentage NRV
method instead, how would it allocate its joint costs?
4. Calculate the gross margin on the sale of the product for human use in March
under the constant gross-margin percentage NRV method.
C
5. Suppose that the separation process also yields 260 pints of a toxic
byproduct. Harrow currently pays a hauling company $6,100 to dispose of this
byproduct. Harrow is contacted by a firm interested in purchasing a modified
form of this byproduct for a total price of $7,300. Harrow estimates that it will
cost about $40 per pint to do the required modification. Should Harrow accept
the offer?
X
More info
Chemicals costing $45,000 are mixed and heated, then a unique separation
process then extracts the drug from the mixture. A batch yields a total of 3,600
gallons of the chemicals. The first 3,000 gallons are sold for human use while the
last 600 gallons, which contain impurities, are sold to veterinarians. The costs
of mixing, heating, and extracting the drug amount to $649,200 per batch. The
output sold for human use is pasteurized at a total cost of $168,000 and is sold for
$630 per gallon. The product sold to veterinarians is irradiated at a cost of $19 per
gallon and is sold for $490 per gallon.
Print
Done
X
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 5 steps with 3 images
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![Horngren's Cost Accounting: A Managerial Emphasis…](https://www.bartleby.com/isbn_cover_images/9780134475585/9780134475585_smallCoverImage.gif)
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
![Intermediate Accounting](https://www.bartleby.com/isbn_cover_images/9781259722660/9781259722660_smallCoverImage.gif)
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
![Financial and Managerial Accounting](https://www.bartleby.com/isbn_cover_images/9781259726705/9781259726705_smallCoverImage.gif)
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education